Search Results - "Azuri, J"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Impact of patients’ access to medical records in occupational medicine by Krakov, A, Kabaha, N, Azuri, J, Moshe, S

    Published in Occupational medicine (Oxford) (20-06-2018)
    “…Abstract Background Information technologies offer new ways to engage with patients regarding their health, but no studies have been done in occupational…”
    Get full text
    Journal Article
  2. 2

    The diagnostic value of 14-3-3η protein levels in patients with rheumatoid arthritis by Shovman, O., Gilburd, B., Watad, A., Amital, H., Langevitz, P., Bragazzi, N.L., Adawi, M., Perez, D., Bornstein, G., Grossman, C., Lidar, M., Blank, M., Azuri, J., Biln, N.K., Marotta, A., Shoenfeld, Y.

    “…14-3-3η may represent a useful diagnostic biomarker for rheumatoid arthritis (RA). We assessed the prevalence and serum levels of 14-3-3η in patients with RA…”
    Get full text
    Journal Article
  3. 3

    Assessment of the underestimation of childhood diarrhoeal disease burden in Israel by ZIV, T., HEYMANN, A. D., AZURI, J., LESHNO, M., COHEN, D.

    Published in Epidemiology and infection (01-09-2011)
    “…We determined the extent by which mandatory reporting on isolates of Shigella and Salmonella underestimates the burden of diarrhoeal diseases in individuals…”
    Get full text
    Journal Article
  4. 4

    Raising awareness for the diagnosis and treatment of erectile dysfunction in patients with high risk to develop ED by Azuri, J, Gelerenter, R, Dushinat, M, Friedman, N, Kokia, E

    “…Prevalence of erectile dysfunction (ED) increases with age and is associated with chronic comorbidities, such as diabetes and hypertension. Even so, ED is…”
    Get full text
    Journal Article
  5. 5

    Liver Damage Due to Alendronate by Halabe, A, Lifschitz, B M, Azuri, J

    Published in The New England journal of medicine (03-08-2000)
    “…To the Editor: Alendronate is indicated for the treatment of postmenopausal women with osteoporosis and patients with glucocorticoid-induced osteoporosis. 1 We…”
    Get full text
    Journal Article
  6. 6

    Colchicine for secondary prevention of cardiovascular disease, a cost per outcome analysis by Tsaban, G, Alnsasra, H, El Nasasra, A, Aboalhasan, E, Azuri, J, Hammerman, A, Arbel, R

    Published in European journal of preventive cardiology (11-05-2022)
    “…Abstract Funding Acknowledgements Type of funding sources: None. Introduction Pharmacological modulation of systemic inflammation significantly reduced…”
    Get full text
    Journal Article
  7. 7

    Sacubitril/valsartan versus in empagliflozin heart failure with preserved ejection fraction by Alnsasra, H, Tsaban, G, Aboalhasan, E, El Nasasra, A, Azuri, J, Hammerman, A, Arbel, R

    Published in European journal of preventive cardiology (11-05-2022)
    “…Abstract Funding Acknowledgements Type of funding sources: None. Background Heart failure with preserved ejection fraction (HFpEF) is associated with frequent…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Insulin/weight ratio may serve as a predictor of success during insulin pump therapy in type 2 diabetes patients: a proof-of-concept study by Levit, Shmuel, Filippov, Yury Ivanovich, Cohen, Ohad, Weichman, Maria, Azuri, Joseph, Manisteski, Yossi, Levit, Vyacheslav Moiseevich

    Published in Sakharnyĭ diabet (01-01-2015)
    “…Aims. To evaluate long-term efficacy of CSII for treating type 2 diabetes patients. To make an attempt to predict which patient would be more likely to reduce…”
    Get full text
    Journal Article
  14. 14

    Systematic Inventive Thinking: a new tool for the analysis of complex problems in medical management by Heymann, Anthony D, Azuri, Joseph, Kokia, Ehud, Monnickendam, Shlomo M, Shapiro, Mervyn, Shalev, Guzu

    Published in The Israel Medical Association journal (01-02-2004)
    “…The complexity of medical problems is a well-recognized phenomenon. In the presence of economic and cultural restrictions, medical decision-making can be…”
    Get full text
    Journal Article
  15. 15

    Asymptomatic Gaucher disease implications for large-scale screening by Azuri, J, Elstein, D, Lahad, A, Abrahamov, A, Hadas-Halpern, I, Zimran, A

    Published in Genetic testing (1998)
    “…Gaucher disease, the most prevalent genetic disorder among Ashkenazi Jews, is characterized by significant phenotypic heterogeneity. Because seven mutations…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Neurological involvement in a child with the wrinkly skin syndrome by Azuri, Joseph, Mizrachi, Avraham, Weintraub, Shlomo, Lerman-Sagie, Tally

    Published in American journal of medical genetics (01-01-1999)
    “…In 1973, a syndrome was reported comprising of wrinkled skin over the dorsum of hands, feet, and abdomen, reduced skin elasticity, skeletal involvement,…”
    Get full text
    Journal Article